glp 1 agonist new drug Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Eli Lilly to seek approval

Now weve entered a new era of weight loss with a groundbreaking class of medications known as GLP-1 inhibitors

The phentermine plus semaglutide combination has gained attention in clinical practice, though research on this specific pairing remains limited

Congress and the FDA should require compounders to disclose the FDA-registered source of their ingredients and block imports from unregistered suppliers

Part D plan sponsors needed to apply to participate in the model by April 20, 2026

Try the BMI Calculator Table of contents The complete list: every GLP-1 receptor agonist by generic and brand name What most articles get wrong about GLP-1 drug classification Pure GLP-1 agonists vs dual agonists: why the distinction matters The brand name confusion problem: why semaglutide has three names Compounded GLP-1 medications: naming conventions and legal status The FormBlends Drug Name Classification System Discontinued and pipeline GLP-1 medications Generic availability timeline: when patents expire How to identify which GLP-1 medication you're taking The decision tree: matching drug names to your treatment goal FAQ Sources The complete list: every GLP-1 receptor agonist by generic and brand name The table below includes every FDA-approved GLP-1 receptor agonist and dual agonist as of April 2026, organized by approval date